Richard Bagley
President at Samus Therapeutics, Inc.
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Tyler Cook | M | - | - | |
| Jonathan Lewis | M | 65 |
ZIOPHARM, Inc.
| 11 years |
| Kevin Lafond | M | 68 | 12 years | |
| Robert Morgan | M | - | - | |
| Michael Weiser | M | 61 |
ZIOPHARM, Inc.
| 15 years |
| Robert Newman | M | - | 3 years | |
| Lynn M. Ferrucci | F | - | 9 years | |
| Tim McInerney | M | 63 |
ZIOPHARM, Inc.
| 10 years |
| James Cannon | M | 85 |
ZIOPHARM, Inc.
| 15 years |
| Murray Brennan | M | 84 |
ZIOPHARM, Inc.
| 14 years |
| Wyche Fowler | M | 83 |
ZIOPHARM, Inc.
| 14 years |
| Caesar Belbel | M | 64 | 7 years | |
| Gary Fragin | M | 77 |
ZIOPHARM, Inc.
| 6 years |
| Brian Schwartz | M | 52 | - | |
| J. Kris Piper | M | - | - | |
| Julian Adams | M | 69 |
ProScript, Inc.
 ProScript, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., ProScript, Inc. is a company that develops anti-cancer treatments. The company is based in Cambridge, MA. The company was founded by Tom Maniatis. ProScript was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on July 20, 1999 for $3.35 million. | 5 years |
| Jason Amello | M | 55 | 1 years | |
| Steven Bloom | M | 63 | 6 years | |
| Randal Kirk | M | 70 | 7 years | |
| Tom Maniatis | M | 80 |
ProScript, Inc.
ProScript, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., ProScript, Inc. is a company that develops anti-cancer treatments. The company is based in Cambridge, MA. The company was founded by Tom Maniatis. ProScript was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on July 20, 1999 for $3.35 million. | - |
| Barry Jones | M | 74 | - | |
| Carlo Casulo | M | - | - | |
| Thomas Malefyt | M | - |
Smithkline & French Laboratories US, Inc.
| - |
| Janice Stevens | F | - | 3 years | |
| Michael King | M | 63 | 1 years | |
| Dean P. Taylor | M | - |
Smithkline & French Laboratories US, Inc.
| - |
| Mark Thornton | M | - | 1 years | |
| Hagop Youssoufian | M | 67 | 2 years | |
| Barbara Fox | M | - |
ImmuLogic Pharmaceutical Corp.
 ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology ImmuLogic Pharmaceutical Corporation is a biopharmaceutical company. The company focuses on the research and clinical development of products to treat allergies, autoimmune diseases, and vaccines for the management of drugs of abuse. It was founded on March 26, 1987 and is headquartered in Woburn, MN. | - |
| Keith Marshall | M | 56 |
ImmuLogic Pharmaceutical Corp.
ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology ImmuLogic Pharmaceutical Corporation is a biopharmaceutical company. The company focuses on the research and clinical development of products to treat allergies, autoimmune diseases, and vaccines for the management of drugs of abuse. It was founded on March 26, 1987 and is headquartered in Woburn, MN. | 3 years |
| Dean H. Taylor | M | - |
Smithkline & French Laboratories US, Inc.
| 10 years |
| Stanley Crooke | M | 78 |
Smithkline & French Laboratories US, Inc.
| 9 years |
| Brian L. Hamilton | M | 76 | 1 years | |
| David J. Ecker | M | 69 |
Smithkline & French Laboratories US, Inc.
| 5 years |
| Robert G. L. Shorr | M | 71 |
Smithkline & French Laboratories US, Inc.
| 6 years |
| Robert P. Gale | M | - | 3 years | |
| Mark Owens Thornton | M | 66 |
ZIOPHARM, Inc.
| 4 years |
| Roger W. Brimblecombe | M | 94 |
Smithkline & French Laboratories US, Inc.
| 11 years |
| Thomas A. Shea | M | 64 |
ImmuLogic Pharmaceutical Corp.
ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology ImmuLogic Pharmaceutical Corporation is a biopharmaceutical company. The company focuses on the research and clinical development of products to treat allergies, autoimmune diseases, and vaccines for the management of drugs of abuse. It was founded on March 26, 1987 and is headquartered in Woburn, MN. | 6 years |
| Sidney M. Hecht | M | 80 |
Smithkline & French Laboratories US, Inc.
| 6 years |
| John Richards | M | 67 |
ImmuLogic Pharmaceutical Corp.
ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology ImmuLogic Pharmaceutical Corporation is a biopharmaceutical company. The company focuses on the research and clinical development of products to treat allergies, autoimmune diseases, and vaccines for the management of drugs of abuse. It was founded on March 26, 1987 and is headquartered in Woburn, MN. | 4 years |
| Malcolm Morville | M | 78 |
ImmuLogic Pharmaceutical Corp.
ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology ImmuLogic Pharmaceutical Corporation is a biopharmaceutical company. The company focuses on the research and clinical development of products to treat allergies, autoimmune diseases, and vaccines for the management of drugs of abuse. It was founded on March 26, 1987 and is headquartered in Woburn, MN. | 5 years |
| George Abercrombie | M | 69 | - | |
| Dan R. Burns | M | 72 |
ProScript, Inc.
ProScript, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., ProScript, Inc. is a company that develops anti-cancer treatments. The company is based in Cambridge, MA. The company was founded by Tom Maniatis. ProScript was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on July 20, 1999 for $3.35 million. | 1 years |
| Kevin P. Lawler | M | - |
ImmuLogic Pharmaceutical Corp.
ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology ImmuLogic Pharmaceutical Corporation is a biopharmaceutical company. The company focuses on the research and clinical development of products to treat allergies, autoimmune diseases, and vaccines for the management of drugs of abuse. It was founded on March 26, 1987 and is headquartered in Woburn, MN. | 8 years |
| Barbara Wallner | M | - | - | |
| Leonard S. Jacob | M | 75 |
Smithkline & French Laboratories US, Inc.
| 9 years |
| Brian Dickson | M | - |
Smithkline & French Laboratories US, Inc.
| 9 years |
| Bruce D. Hirsche | M | 76 | 1 years | |
| David Lubner | M | 60 |
ProScript, Inc.
ProScript, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., ProScript, Inc. is a company that develops anti-cancer treatments. The company is based in Cambridge, MA. The company was founded by Tom Maniatis. ProScript was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on July 20, 1999 for $3.35 million. | 3 years |
| Amy Mendel | F | 44 | 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 50 | 98.04% |
| Canada | 1 | 1.96% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Richard Bagley
- Personal Network
